Vazhaikkurichi Rajendran

Has grant

Professor

West Virginia University
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

Aldosterone Activation of Trans-epithelial Iron Absorption in Human Colon

Open Date: 2018-09-01

Close Date: 2021-04-30

Grant: Close

Role of BK Channels in K+-driven Colonic Water Secretion in Health and Disease

Open Date: 2015-09-23

Close Date: 2021-08-31

Grant: Close

Role of IK channels in rat distal colon

Open Date: 1976-06-01

Close Date: 2013-08-31

Articles (8)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

The global prevalence of ulcerative colitis (UC) and Crohn’s disease (CD) is increasing, placing greater burdens on national health systems. The pathophysiology of diarrhea, the commonest debilitating symptom in patients with UC and CD, has been studied more extensively in UC, where it reflects defective colonic Na + absorption combined with changes in colonic Cl − and K + transport, which significantly reduce colonic water absorption. Dysfunctional ion transport in patients with UC is accompanied by abnormalities in tight junctional protein distribution and function, which cause the inflamed colonic epithelium to become “leakier.” Progress in understanding how abnormal colonic ion transport in UC might be influenced pharmacologically has been hampered by the low availability of clinical material. To counter this, various animal models of acute colitis have been developed, but differ in the way mucosal inflammation is induced. Identifying models that closely mimic human UC in terms of pathology and ion transport abnormalities remains challenging. However, the introduction of human colonic epithelial organoids (colonoids) has added a new and exciting dimension to research in this area. Here, we review current knowledge about abnormal colonic ion transport and barrier function in experimental and human colitis as well as the use and potential of human colonoids to better understand the pathophysiology of UC, which may ultimately lead to novel approaches to the treatment of diarrhea in this disease.

Year:

2025

Somatostatin (SOM, 2 µM) and octreotide (OCT, 0.2 µM, a long-acting synthetic analog of SOM) were equally effective in preventing chemical hypoxia-induced increases in paracellular shunt permeability/conductance in isolated human colon. In rat distal colon, chemical hypoxia significantly increased total epithelial conductance and transepithelial movement of FITC-dextran 4000, changes completely prevented by 0.2 µM OCT. OCT may prevent or limit gut ischemia during abdominal surgery, thereby decreasing the risk of bacterial/bacterial toxin translocation and sepsis.

Year:

2024

Year:

2023

Year:

2023

Collaborators (3)

Joshua Cornman-Homonoff

Assistant Professor

Yale New Haven Hospital

UNITED STATES
View details

Karthikeyan Narayanan

Director, Stem Cell Core

Rensselaer Polytechnic Institute

UNITED STATES
View details

Roberta Leonardi

West Virginia University

UNITED STATES
View details